• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Privacy Beyond HIPAA in Voice Technology

Share:

August 20, 2019

Industry players warn that while voice technology has the ability to reach a larger audience, it must be implemented with privacy as a top priority.

While voice has been touted as an emerging technology with the ability to lower the bar to entry, industry players are now starting to warn of privacy gaps. Amazon Alexa and Google Home devices are now becoming a frequent household item, used for everything from ordering a new wardrobe to helping with homework.

But when used in the medical industry, the technology needs to be administered differently than in the consumer world.

“When it comes to healthcare and voice design, we have several challenges we face every day,” Freddie Feldman, voice design director at Wolters Kluwer Health, said at The Voice of Healthcare Summit at Harvard Medical School last week. “HIPAA is a big topic on everyone’s mind nowadays, and it is one we take seriously. The first thing most people think about when they hear HIPAA is securing servers platforms, but there is more to it. We have to consider things like the unintended audience for a call.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

He said that due to the nature of voice, even leaks not expressly prohibited by HIPAA can be inappropriate. For example, if the voice technology is intended for home use and gives a message from the radiology department to the house, then it’s giving away too much information, he said.

Much of it comes down to appropriate use. For example, putting the speakers into a hospital room setting poses a different set of challenges.

“I think as far as smart speakers and virtual assistants [go], Amazon right now only has HIPAA-eligible environments, so basically turning on and off HIPAA for specific skills, enabling HIPAA for a particular voice app or voice skill,” Sarah Lindenauer, product and portfolio manager of the innovation and digital health accelerator (IDHA) at Boston Children’s Hospital, said at MassBio’s forum on Using Clinical Data from wearables and voice.

“Right now, it’s invite-only and only select developers or partners would develop skills that process PHI in a HIPAA-compliant manner. That is great and a step in the right directions. But when you think about placing a smart speaker in a hospital room, there is a whole host of considerations. … The entire platform isn’t HIPAA compliant and you can’t tell, if it’s patient facing, how the patient is going to use it and the type of information they are going to share, and whether they are going to stay in that one skill that is deemed HIPAA compliant.”
The provider setting

Providers are also starting to use voice to do their work, both in the exam room and in their prep work.

“In healthcare you have to [look at] the design considerations and the advantages and disadvantages of speaking. You have to think about some of the privacy considerations of public versus private, and the concept of someone listening to you and also overhearing things that you might not want said out loud,” Dr. Yaa Kumah, assistant professor of biomedical informatics at Vanderbilt University Medical Center, said at The Voice of Healthcare Summit.

She went on to say that there are many use cases where voice could be appropriate. For example, the technology could help providers pull up critical information during patient exams, allowing clinicians more face-to-face time with patients. This scenario also comes with its own set of challenges. She brought up the situation where a patient may come into the room with a support person.

“If the patient is in the room and they are there with a friend and you are asking what medications are you being treated for — is that something that you need a voice assistant to assert out loud or do you suppress different kinds of information in the chart that could be considered sensitive? If you do that, does that add to the stigma? These are all things we are figuring out.”

Another situation where voice could be beneficial is patient briefings. For example, when doctors are in the privacy of their own car, they could get updates on their patients’ conditions as they commute to work. This also has its own set of concerns. Kumah said that you wouldn’t want to use the same type of technology if you are in a public location.
The appropriate setting

“Transitioning from one place to another [is important]. You are rounding on your patients and need to know something about the next person before you see them,” Kumah said. “So, unlike the car that is more or less private, you are on an elevator or in the hallway, so maybe it is not appropriate to speak aloud the entire summary for the patient. But maybe the tech can [sense] if you have headphones in and only then will it speak it aloud rather than displaying it on the [phone].”

It’s not only the providers that need to be able to transition modes of communication, but also patients.

“For example, there are some private conversations you might want to have by text because you don’t want to be walking down the street and your phone goes off and says, ‘Don’t forget to take your Viagra today,’” Shwen Gwee, cofounder of Novartis Biome and global head of Open Innovations at Novartis, said during Voice Summit. “When you are at home, voice is much easier to do.”

At the end of the day, industry players say in order for this technology to work it has to be about figuring out the time to use and the time not to use it.

“I always like to ask what is the best channel to ask this question, and what is the best channel to receive it,” Lexi Kaplin, cofounder and chief product officer at conversationHEALTH, said during the voice forum.

Date: August 20, 2019

Source: Mobihealth News

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Samsung, b.well Partner to Provide Longitudinal Data to Galaxy Smartphone UsersSamsung, b.well Partner to Provide Longitudinal Data to Galaxy Smartphone Users
  • Humana and Epione Health Team up to Offer a Patient-centered Experience for Humana Medicare Advantage Members in OklahomaHumana and Epione Health Team up to Offer a Patient-centered Experience for Humana Medicare Advantage Members in Oklahoma
  • BrightInsight Raises $40M in Series B Funding to Cement its Position as the Leading Global Regulated Digital Health Platform for Biopharma and MedtechBrightInsight Raises $40M in Series B Funding to Cement its Position as the Leading Global Regulated Digital Health Platform for Biopharma and Medtech
  • Protech Announces Execution of LOI to Acquire a Profitable Leading Supplier of Respiratory Therapy Products and Services in the Southeastern U.S.Protech Announces Execution of LOI to Acquire a Profitable Leading Supplier of Respiratory Therapy Products and Services in the Southeastern U.S.
  • Health Startup MediCircle Brings AI-Powered Rapid COVID-19 Test to IndiaHealth Startup MediCircle Brings AI-Powered Rapid COVID-19 Test to India
  • SynsorMed, Charles Barkley Foundation Partner to Combat Health Disparities for Black Americans Impacted by COVID-19SynsorMed, Charles Barkley Foundation Partner to Combat Health Disparities for Black Americans Impacted by COVID-19
  • Exelixis and Cybrexa Therapeutics Establish Exclusive Collaboration Providing Exelixis the Right to Acquire CBX-12, a Potential First-in-class Peptide-drug Conjugate of ExatecanExelixis and Cybrexa Therapeutics Establish Exclusive Collaboration Providing Exelixis the Right to Acquire CBX-12, a Potential First-in-class Peptide-drug Conjugate of Exatecan
  • PacBio and ARUP Laboratories Collaborate in a Study to Improve Rare Disease DiagnosisPacBio and ARUP Laboratories Collaborate in a Study to Improve Rare Disease Diagnosis

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications